The Trading Window of the Company shall remain closed from Thursday, January 1, 2026 till 48 hours after the declaration of Un-audited financial results for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samrat Pharmachem Limited has informed BSE that its trading window will remain closed starting Thursday, January 1, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ended December 31, 2025. The closure is in line with SEBI's Insider Trading Regulations, 2015 and the company's internal Code of Conduct. During this period, all designated persons and their immediate relatives are barred from buying, selling, or pledging shares of the company. The notice has been signed by Nishant Kankaria, Company Secretary and Compliance Officer, on December 29, 2025.
This is a routine regulatory compliance notice before quarterly results and does not signal any insider activity. Investors should expect the unaudited Q3 FY26 results to be announced shortly after the window reopens.